Ultrack Systems Inc. (OTC: MJLB) Launches "PUR Rx" - A Scalable Digital Healthcare Platform Through Joint Venture with Synergy Health Rx Corp.
MWN-AI** Summary
Ultrack Systems Inc. (OTC: MJLB) has announced the launch of PUR Rx, an innovative digital healthcare platform formed through a joint venture with Synergy Health Rx Corp. The platform aims to revolutionize access to prescribed therapies across Canada by integrating digital technologies with established healthcare systems. With the Canadian digital health market projected to surpass CAD $4.7 billion by 2026, PUR Rx is strategically entering a growing sector characterized by virtual care and personalized treatment.
CEO Reno Calabrigo emphasized that PUR Rx represents a significant advancement in digital healthcare. The platform will harness Ultrack’s strengths in digital marketing and user acquisition alongside Synergy Health’s expertise in healthcare regulation and infrastructure. Key features of PUR Rx include virtual care access, prescription management through a licensed network, and secure communication portals for patients and providers.
Ultrack plans to drive growth through targeted digital marketing campaigns and strategic outreach, investing up to $10,000 quarterly in marketing through 2025. This investment aims to lower customer acquisition costs, allowing PUR Rx to gain traction in the competitive landscape inhabited by larger players like WELL Health Technologies and Dialogue Health Technologies. The platform will also benefit from joint ownership of patient data, essential for upcoming regulatory compliance and operational scaling.
Looking ahead, PUR Rx targets annual revenue growth of 25% to 30% over the next three years, leveraging various revenue streams including service fees and prescription margins. Expansion into other Canadian provinces and telehealth integrations are also on the horizon.
As healthcare increasingly transitions to virtual care models, Ultrack’s launch of PUR Rx positions it at the forefront of evolving healthcare delivery, appealing to investors focused on innovative, technology-driven solutions in the industry.
MWN-AI** Analysis
Ultrack Systems Inc. (OTC: MJLB) has recently launched the PUR Rx platform through a joint venture with Synergy Health Rx Corp, positioning itself strategically within Canada's rapidly growing digital health market, projected to reach CAD $4.7 billion by 2026. This initiative is significant, as it combines Ultrack's technological prowess and digital marketing expertise with Synergy's established healthcare infrastructure, setting the stage for a successful market entry.
Investors should take note of the platform’s potential to disrupt traditional healthcare delivery models, especially in a post-pandemic landscape where virtual care and digital solutions are increasingly favored. Focused on enhancing patient access to therapies, PUR Rx offers features such as virtual care access, prescription management, and secure portals—all of which are essential for maximizing patient engagement and retention.
Ultrack's commitment to invest up to $10,000 quarterly in marketing campaigns through 2025 reflects an aggressive push to drive user acquisition with potential for growth in 2026 as the platform expands across Canada. The company aims for 25%–30% annual revenue growth, primarily through recurring service fees, capitalizing on its scalable model.
While Ultrack faces competition from established players like WELL Health Technologies, PUR Rx's differentiators include joint ownership of infrastructure, built-in compliance mechanisms, and lower customer acquisition costs. By capitalizing on its agility, Ultrack can quickly adapt to emerging markets or underserved regions, enhancing investor appeal.
In summary, Ultrack Systems Inc. presents an exciting opportunity for investors interested in the future of digital healthcare delivery. With a robust partnership and a scalable business model poised to capture a significant market share, MJLB is a stock to watch as healthcare becomes increasingly tech-driven.
**MWN-AI Summary and Analysis is based on asking OpenAI to summarize and analyze this news release.
CONCORD, Ontario, June 26, 2025 (GLOBE NEWSWIRE) -- Ultrack Systems Inc. (OTC: MJLB) is excited to announce the official launch of PUR Rx , a next-generation digital health platform formed through a 50/50 joint venture with Synergy Health Rx Corp. Designed to transform how Canadians access prescribed therapies, PUR Rx merges digital innovation with trusted medical infrastructure to deliver patient-first care at scale.
With the market for digital health in Canada expected to exceed CAD $4.7 billion by 2026 (Statista) and showing compound annual growth of 8.3% , PUR Rx arrives at a pivotal moment. The platform is poised to capture significant share in a sector driven by virtual care, streamlined prescriptions, and personalized healthcare delivery.
“PUR Rx is more than a joint venture—it’s a bold leap forward into the future of digital medicine,” said Reno Calabrigo, CEO of Ultrack Systems Inc. “This initiative perfectly blends our technology and branding strengths with Synergy Health’s healthcare credibility and regulatory footprint.”
Positioned at the Crossroads of Digital Health & Revenue Recurrence
PUR Rx leverages Ultrack’s proven capabilities in digital marketing, smart logistics, and user acquisition to accelerate platform growth and patient enrollment. Simultaneously, Synergy Health Rx contributes licensed infrastructure, prescription fulfillment, and a robust patient network, offering immediate operational scalability and regulatory compliance.
Key Platform Features:
- Virtual care access & real-time eligibility checks
- Prescription management through a licensed network
- Secure portals for patients and providers
- Data-driven marketing funnel to increase LTV (lifetime value) per user
Marketing-Driven Expansion with Ultrack at the Helm
Ultrack will lead the strategic rollout and brand development of PUR Rx through:
- Paid digital campaigns targeting specific therapeutic verticals
- SEO/SEM and geo-targeted outreach across Ontario
- B2C and B2B lead funnels for patient and clinic acquisition
- Investor-focused awareness campaigns and quarterly updates
Ultrack has committed to funding up to $10,000 per quarter in marketing spend through 2025 , reflecting a lean but impactful customer acquisition strategy. This figure is expected to grow in 2026 as PUR Rx expands its footprint across Canada.
Competitive Advantage: Combining Agility with Compliance
While larger public digital health players like WELL Health Technologies and Dialogue Health Technologies have shown strong investor interest based on revenue growth and SaaS-style healthcare delivery models, PUR Rx differentiates itself through:
- Joint ownership of infrastructure and patient data
- Built-in fulfillment and regulatory compliance
- Lower CAC (customer acquisition cost) due to Ultrack's digital edge
- Agility to pivot into emerging markets or underserved communities
These advantages offer institutional upside and retail investor appeal , especially as digital-first healthcare becomes the new norm post-pandemic.
Financial Outlook: Recurring Revenue, Scalable Model
The PUR Rx venture is targeting 25%–30% annual revenue growth over the next three years , supported by recurring service fees, prescription margins, and third-party payer partnerships. As the platform gains traction, expansion into additional Canadian provinces and telehealth integrations will enable new revenue streams and possible white-label licensing opportunities.
About Ultrack Systems Inc.
Ultrack Systems Inc. (OTC: MJLB) is a technology and logistics innovator focused on digital marketing, smart infrastructure, and operational scale across healthcare, transportation, and enterprise verticals. The company enables growth through turnkey branding systems, digital outreach, and strategic partnerships.
About Synergy Health Rx Corp.
Synergy Health Rx Corp. is a licensed health services provider specializing in prescription management, patient education, and coordinated care delivery across Ontario. Known for its advocacy-first approach, the company brings operational excellence and compliance assurance to PUR Rx.
INVESTOR NOTE:
With healthcare increasingly shifting toward virtual care, tech-enabled prescribing , and personalized patient experiences , MJLB’s launch of PUR Rx marks a high-leverage entry into a multi-billion-dollar, high-retention industry . Investors seeking exposure to the future of healthcare delivery—and the platforms that power it—should be watching Ultrack Systems Inc. closely.
Safe Harbor Statement
This Press Release may contain certain forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. The Company has tried, whenever possible, to identify these forward-looking statements using words such as "anticipates," "believes," "estimates," "expects," "plans," "intends," "potential" and similar expressions. These statements reflect the Company's current beliefs and are based upon information currently available to it. Accordingly, such forward-looking statements involve known and unknown risks, uncertainties and other factors which could cause the Company's actual results, performance or achievements to differ materially from those expressed in or implied by such statements. The Company undertakes no obligation to update or advise in the event of any change, addition or alteration to the information catered in this Press Release, including such forward-looking statements.
Investor Contact:
Email: info@ultrack.ca
Web: ultrack.ca , mybetterpets.com X: @UltrackI
FAQ**
How does Ultrack Systems Inc MJLB plan to maintain a competitive edge against larger players like WELL Health Technologies and Dialogue Health Technologies in the evolving digital health market?
What strategies will Ultrack Systems Inc MJLB implement to ensure patient enrollment on the PUR Rx platform, particularly in underserved communities that may benefit from telehealth services?
Can you elaborate on the projected revenue growth of 25%–30% annually for PUR Rx, and what specific factors are driving this optimistic financial outlook for Ultrack Systems Inc MJLB?
What measures are in place for Ultrack Systems Inc MJLB to address potential risks associated with regulatory compliance within the digital health landscape as PUR Rx expands across Canada?
**MWN-AI FAQ is based on asking OpenAI questions about Ultrack Systems Inc (OTC: MJLB).
NASDAQ: MJLB
MJLB Trading
0.0% G/L:
$0.0001 Last:
5,966 Volume:
$0.0001 Open:
